Norges Bank’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-391,100
Closed -$5.39M 2094
2022
Q4
$5.39M Buy
+391,100
New +$5.44M ﹤0.01% 1760
2018
Q2
Sell
-24,185
Closed -$417K 2128
2018
Q1
$417K Sell
24,185
-514,667
-96% -$8.58M ﹤0.01% 2100
2017
Q4
$8.96M Sell
538,852
-26,244
-5% -$448K ﹤0.01% 1777
2017
Q3
$9.66M Hold
565,096
﹤0.01% 1744
2017
Q2
$9.16M Buy
565,096
+60,000
+12% +$949K ﹤0.01% 1762
2017
Q1
$8.76M Buy
505,096
+345,096
+216% +$5.77M ﹤0.01% 1776
2016
Q4
$2.7M Buy
160,000
+100,000
+167% +$1.67M ﹤0.01% 1943
2016
Q3
$1M Buy
+60,000
New +$973K ﹤0.01% 2045

Other funds holding ANGO

Norges Bank's ANGO Position: Q1 2023 in Review

Norges Bank sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 391,100 shares — an estimated $5.39M sold.

Norges Bank first reported a position in ANGO in Q3 2016 and held it in 8 quarters. The position peaked at $9.66M in Q3 2017. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

  • Norges Bank reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
  • Norges Bank sold 391,100 AngioDynamics shares in Q1 2023, an estimated $5.39M.
  • Norges Bank first reported a position in AngioDynamics in Q3 2016 and held it in 8 quarters.
  • Norges Bank's AngioDynamics position peaked at $9.66M in Q3 2017.
  • 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.